Posttranslational modulation of FoxO1 contributes to cardiac remodeling in post-ischemic heart failure

Atherosclerosis

Volumn 249, Issue , 2016, Pages 148-156

  Kappel, Ben Arpad ^a,b   Stöhr, Robert ^a,b   De Angelis, Lorenzo ^a   Mavilio, Maria ^a   Menghini, Rossella ^a   Federici, Massimo ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Acetylation; Cardiac remodeling; Diabetes; FoxO1; Heart failure; Myocardial infarction; Posttranslational modification

Indexed keywords

COLLAGEN; FOXO1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR FKHR;

ACETYLATION; ANIMAL; BLOOD; C57BL MOUSE; DOWN REGULATION; ENERGY METABOLISM; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HEMODYNAMICS; MALE; METABOLISM; METABOLOMICS; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING;

ACETYLATION; ANIMALS; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; ENERGY METABOLISM; FORKHEAD BOX PROTEIN O1; GENE EXPRESSION REGULATION; HEART FAILURE; HEMODYNAMICS; MALE; METABOLOMICS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; VENTRICULAR REMODELING;

EID: 84963721844     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.04.001     Document Type: Article

References (51)

1. Roger V.L. Epidemiology of heart failure. Circ. Res. 2013, 113:646-659. 10.1161/CIRCRESAHA.113.300268.
2. Harjai K.J., Stone G.W., Boura J., Mattos L., Chandra H., Cox D., et al. Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. Am. J. Cardiol. 2003, 91:1041-1045. 10.1016/S0002-9149(03)00145-0.
3. Almdal T., Scharling H., Jensen J.S., Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch. Intern. Med. 2004, 164:1422-1426. 10.1001/archinte.164.13.1422.
4. Kappel B., Marx N., Federici M. Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials. Nutr. Metab. Cardiovasc. Dis. 2015, 25:697-705. 10.1016/j.numecd.2015.06.006.
5. Stanley W.C., Lopaschuk G.D., McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc. Res. 1997, 34:25-33. 10.1016/S0008-6363(97)00047-3.
6. Fillmore N., Mori J., Lopaschuk G.D. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br. J. Pharmacol. 2014, 171:2080-2090. 10.1111/bph.12475.
7. Wende A.R. Post-translational modifications of the cardiac proteome in diabetes and heart failure. Proteom. Clin. Appl. 2016, 10:25-38. 10.1002/prca.201500052.
8. Accili D., Arden K.C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004, 117:421-426. 10.1016/S0092-8674(04)00452-0.
9. Sengupta A., Molkentin J.D., Yutzey K.E. FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 2009, 284:28319-28331. 10.1074/jbc.M109.024406.
10. Nakae J., Oki M., Cao Y. The FoxO transcription factors and metabolic regulation. FEBS Lett. 2008, 582:54-67. 10.1016/j.febslet.2007.11.025.
11. Barthel A., Schmoll D., Unterman T.G. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 2005, 16:183-189. 10.1016/j.tem.2005.03.010.
12. Puthanveetil P., Wan A., Rodrigues B. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovasc. Res. 2013, 97:393-403. 10.1093/cvr/cvs426.
13. Qiang L., Banks A.S., Accili D. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J. Biol. Chem. 2010, 285:27396-27401. 10.1074/jbc.M110.140228.
14. Frescas D., Valenti L., Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 2005, 280:20589-20595. 10.1074/jbc.M412357200.
15. Daitoku H., Sakamaki J.I., Fukamizu A. Regulation of FoxO transcription factors by acetylation and protein-protein interactions. Biochim. Biophys. Acta - Mol. Cell Res. 2011, 1813:1954-1960. 10.1016/j.bbamcr.2011.03.001.
16. Zhao Y., Yang J., Liao W., Liu X., Zhang H., Wang S., et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 2010, 12:665-675. 10.1038/ncb2069.
17. Furuyama T., Kitayama K., Shimoda Y., Ogawa M., Sone K., Yoshida-Araki K., et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 2004, 279:34741-34749. 10.1074/jbc.M314214200.
18. Qiang L., Tsuchiya K., Kim-Muller J.-Y., V Lin H., Welch C., Accili D. Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene. J. Biol. Chem. 2012, 287:13944-13951. 10.1074/jbc.M111.332767.
19. Tsuchiya K., Tanaka J., Shuiqing Y., Welch C.L., DePinho R.A., Tabas I., et al. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 2012, 15:372-381. 10.1016/j.cmet.2012.01.018.
20. Tsuchiya K., Banks A.S., Liang C.-P., Tabas I., Tall A.R., Accili D. Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis. Arterioscler. Thromb. Vasc. Biol. 2011, 31:2920-2928. 10.1161/ATVBAHA.110.219477.
21. Tanaka J., Qiang L., Banks A.S., Welch C.L., Matsumoto M., Kitamura T., et al. Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes 2009, 58:2344-2354. 10.2337/db09-0167.
22. Menghini R., Casagrande V., Cardellini M., Ballanti M., Davato F., Cardolini I., et al. FoxO1 regulates asymmetric dimethylarginine via downregulation of dimethylaminohydrolase 1 in human endothelial cells and subjects with atherosclerosis. Atherosclerosis 2015, 242:230-235. 10.1016/j.atherosclerosis.2015.07.026.
23. Chen C.-J., Yu W., Fu Y.-C., Wang X., Li J.-L., Wang W. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 2009, 378:389-393. 10.1016/j.bbrc.2008.11.110.
24. Morris J.B., Kenney B., Huynh H., Woodcock E.a Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists. Endocrinology 2005, 146:4370-4376. 10.1210/en.2005-0162.
25. Ning Y., Li Z., Qiu Z. FOXO1 silence aggravates oxidative stress-promoted apoptosis in cardiomyocytes by reducing autophagy. J. Toxicol. Sci. 2015, 40:637-645. 10.2131/jts.40.637.
26. Evans-Anderson H.J., Alfieri C.M., Yutzey K.E. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ. Res. 2008, 102:686-694. 10.1161/CIRCRESAHA.107.163428.
27. Liu J., Tang Y., Feng Z., Hou C., Wang H., Yan J., et al. Acetylated FoxO1 mediates high-glucose induced autophagy in H9c2 cardiomyoblasts: regulation by a polyphenol -(-)-epigallocatechin-3-gallate. Metabolism 2014, 63:1314-1323. 10.1016/j.metabol.2014.06.012.
28. Puthanveetil P., Wang Y., Zhang D., Wang F., Kim M.S., Innis S., et al. Cardiac triglyceride accumulation following acute lipid excess occurs through activation of a FoxO1-iNOS-CD36 pathway. Free Radic. Biol. Med. 2011, 51:352-363. 10.1016/j.freeradbiomed.2011.04.009.
29. Battiprolu P.K., Hojayev B., Jiang N., V Wang Z., Luo X., Iglewski M., et al. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J. Clin. Investig. 2012, 122:1109-1118. 10.1172/JCI60329.
30. Qi Y., Zhu Q., Zhang K., Thomas C., Wu Y., Kumar R., et al. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and -myosin heavy chain gene expression. Circ. Hear. Fail. 2014, 8:198-208. 10.1161/CIRCHEARTFAILURE.114.001457.
31. Mu J., Woods J., Zhou Y.-P., Roy R.S., Li Z., Zycband E., et al. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes. Diabetes 2006, 55:1695-1704. 10.2337/db05-1602.
32. Wang B., Yang Q., Sun Y., Xing Y., Wang Y., Lu X., et al. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J. Cell. Mol. Med. 2014, 18:1599-1611. 10.1111/jcmm.12312.
33. Stöhr R., Kappel B.A., Carnevale D., Cavalera M., Mavilio M., Arisi I., et al. TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice. Mol. Metab. 2015, 4:741-752. 10.1016/j.molmet.2015.07.007.
34. Shioura K.M., Geenen D.L., Goldspink P.H. Assessment of cardiac function with the pressure-volume conductance system following myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2870-H2877. 10.1152/ajpheart.00585.2007.
35. Xia J., Sinelnikov I.V., Han B., Wishart D.S. MetaboAnalyst 3.0-making metabolomics more meaningful. Nucleic Acids Res. 2015, 43:W251-W257. 10.1093/nar/gkv380.
36. Gilda J.E., Gomes A.V. Stain-Free total protein staining is a superior loading control to β-actin for Western blots. Anal. Biochem. 2013, 440:186-188. 10.1016/j.ab.2013.05.027.
37. Gomes a.V., Waddell D.S., Siu R., Stein M., Dewey S., Furlow J.D., et al. Upregulation of proteasome activity in muscle RING finger 1-null mice following denervation. FASEB J. 2012, 26:2986-2999. 10.1096/fj.12-204495.
38. Lu T.-M., Tsai J.-Y., Chen Y.-C., Huang C.-Y., Hsu H.-L., Weng C.-F., et al. Downregulation of Sirt1 as aging change in advanced heart failure. J. Biomed. Sci. 2014, 21:57. 10.1186/1423-0127-21-57.
39. Hsu C.-P., Zhai P., Yamamoto T., Maejima Y., Matsushima S., Hariharan N., et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010, 122:2170-2182. 10.1161/CIRCULATIONAHA.110.958033.
40. Sin T.K., Yu A.P., Yung B.Y., Yip S.P., Chan L.W., Wong C.S., et al. Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J. Physiol. 2014, 592:2535-2548. 10.1113/jphysiol.2014.271387.
41. Cattelan A., Ceolotto G., Bova S., Albiero M., Kuppusamy M., De Martin S., et al. NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. Vasc. Pharmacol. 2015, 70:35-44. 10.1016/j.vph.2015.02.004.
42. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem. 2010, 285:8340-8351. 10.1074/jbc.M109.088682.
43. Lukaski H.C., Mendez J., Buskirk E.R., Cohn S.H. Relationship between endogenous 3-methylhistidine excretion and body composition. Am. J. Physiol. 1981, 240:E302-E307. (accessed November 25, 2015). http://www.ncbi.nlm.nih.gov/pubmed/7212061.
44. Garvey S.M., Dugle J.E., Kennedy A.D., McDunn J.E., Kline W., Guo L., et al. Metabolomic profiling reveals severe skeletal muscle group-specific perturbations of metabolism in aged FBN rats. Biogerontology 2014, 15:217-232. 10.1007/s10522-014-9492-5.
45. Bruder E.D., Raff H. Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal and young adult rats. Lipids Health Dis. 2010, 9:3. 10.1186/1476-511X-9-3.
46. Kelleher P.C. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone. Clin. Chim. Acta 1979, 92:373-379. (accessed November 25, 2015). http://www.ncbi.nlm.nih.gov/pubmed/436278.
47. Nogueira A.de C., Vale R.G.S., Gomes A.L.M., Dantas E.H.M. The effect of muscle actions on the level of connective tissue damage. Res. Sports Med. 2011, 19:259-270. 10.1080/15438627.2011.608046.
48. Moore K.H., Radloff J.F., Hull F.E., Sweeley C.C. Incomplete fatty acid oxidation by ischemic heart: beta-hydroxy fatty acid production. Am. J. Physiol. 1980, 239:H257-H265. (accessed November 25, 2015). http://www.ncbi.nlm.nih.gov/pubmed/7406063.
49. Sansbury B.E., DeMartino A.M., Xie Z., Brooks A.C., Brainard R.E., Watson L.J., et al. Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts CLINICAL PERSPECTIVE. Circ. Hear. Fail. 2014, 7:634-642. 10.1161/CIRCHEARTFAILURE.114.001151.
50. Banks A.S., Kim-Muller J.Y., Mastracci T.L., Kofler N.M., Qiang L., Haeusler R.A., et al. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab. 2011, 14:587-597. 10.1016/j.cmet.2011.09.012.
51. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 2010, 107:1470-1482. 10.1161/CIRCRESAHA.110.227371.